Cardiac metabolomics is a cutting-edge field of study that focuses on the comprehensive analysis of small molecules involved in the metabolic processes within the heart. This discipline plays a crucial role in unraveling the intricate interplay of metabolites, providing valuable insights into the metabolic pathways associated with cardiovascular health and disease. By examining the dynamic changes in metabolite profiles, researchers gain a deeper understanding of the molecular mechanisms underlying cardiac conditions, paving the way for the development of innovative diagnostic tools and targeted therapeutic interventions. Through the lens of metabolomics, scientists aim to decipher the metabolic signatures associated with various cardiac disorders, offering a promising avenue for advancing personalized medicine and enhancing our ability to detect, monitor, and treat cardiovascular diseases with greater precision.
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India